Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
17.5 SEK | +3.43% | +6.71% | +13.20% |
Apr. 17 | Orexo Expands, Extends US Patent for Nasal Anaphylaxis Treatment | MT |
Apr. 17 | Orexo Extends Patent Protection for Its Nasal Epinephrine Powder Product OX640 in the US | CI |
- Stock Market
- Equities
- ORX Stock
- News Orexo AB